Literature DB >> 15123504

Focal changes in brain energy and phospholipid metabolism in first-episode schizophrenia: 31P-MRS chemical shift imaging study at 4 Tesla.

J Eric Jensen1, Jodi Miller, Peter C Williamson, Richard W J Neufeld, Ravi S Menon, Ashok Malla, Rahul Manchanda, Betsy Schaefer, Maria Densmore, Dick J Drost.   

Abstract

BACKGROUND: Membrane phospholipid and high-energy abnormalities measured with phosphorus magnetic resonance spectroscopy ((31)P-MRS) have been reported in patients with schizophrenia in several brain regions. AIMS: Using improved imaging techniques, previously inaccessible brain regions were examined in patients with first-episode schizophrenia and healthy volunteers with 4.0 T (31)P-MRS.
METHOD: Brain spectra were collected in vivo from 15 patients with first-episode schizophrenia and 15 healthy volunteers from 15 cm(3) effective voxels in the thalamus, cerebellum, hippocampus, anterior/posterior cingulate, prefrontal cortex and parieto-occipital cortex.
RESULTS: People with first-episode schizophrenia showed increased levels of glycerophosphocholine in the anterior cingulate. Inorganic phosphate, phosphocreatine and adenosine triphosphate concentrations were also increased in the anterior cingulate in this group.
CONCLUSIONS: The increased phosphodiester and high-energy phosphate levels in the anterior cingulate of brains of people with first-episode schizophrenia may indicate neural overactivity in this region during the early stages of the illness, resulting in increased excitotoxic neural membrane breakdown.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15123504     DOI: 10.1192/bjp.184.5.409

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  12 in total

Review 1.  Testing models of thalamic dysfunction in schizophrenia using neuroimaging.

Authors:  K Sim; T Cullen; D Ongur; S Heckers
Journal:  J Neural Transm (Vienna)       Date:  2005-10-27       Impact factor: 3.575

Review 2.  Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.

Authors:  Stephen R Dager; Neva M Corrigan; Todd L Richards; Stefan Posse
Journal:  Top Magn Reson Imaging       Date:  2008-04

3.  Characteristics of hemodynamic response functions in the brain of patients with schizophrenia in execution of auditory paradigm oddball.

Authors:  M V Ublinskiy; N A Semenova; T A Akhadov; A V Petryaykin; I S Lebedeva; A F Efremkin; A S Tyurneva; V G Kaleda
Journal:  Dokl Biochem Biophys       Date:  2014-01-03       Impact factor: 0.788

Review 4.  Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies.

Authors:  Anouk Marsman; Martijn P van den Heuvel; Dennis W J Klomp; René S Kahn; Peter R Luijten; Hilleke E Hulshoff Pol
Journal:  Schizophr Bull       Date:  2011-07-11       Impact factor: 9.306

Review 5.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

6.  Phospholipid profile in the postmortem hippocampus of patients with schizophrenia and bipolar disorder: no changes in docosahexaenoic acid species.

Authors:  Kei Hamazaki; Kwang H Choi; Hee-Yong Kim
Journal:  J Psychiatr Res       Date:  2010-01-06       Impact factor: 4.791

Review 7.  Disturbed structural connectivity in schizophrenia primary factor in pathology or epiphenomenon?

Authors:  Andreas Konrad; Georg Winterer
Journal:  Schizophr Bull       Date:  2007-05-07       Impact factor: 9.306

Review 8.  Deconstructing psychosis with human brain imaging.

Authors:  Raquel E Gur; Matcheri S Keshavan; Stephen M Lawrie
Journal:  Schizophr Bull       Date:  2007-06-04       Impact factor: 9.306

Review 9.  Electrophysiological and neuropsychological predictors of conversion to schizophrenia in at-risk subjects.

Authors:  Tomiki Sumiyoshi; Tomohiro Miyanishi; Tomonori Seo; Yuko Higuchi
Journal:  Front Behav Neurosci       Date:  2013-10-21       Impact factor: 3.558

10.  Increased PLA2 activity in individuals at ultra-high risk for psychosis.

Authors:  Leda L Talib; Alana C Costa; Helena P G Joaquim; Cícero A C Pereira; Martinus T Van de Bilt; Alexandre A Loch; Wagner F Gattaz
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-03-06       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.